Thought leaders

Adaptive Trial Design for Phase I, Phase II

Adaptive trial design is a hot issue in…
Read Article

Transforming Oncology Drug Development with Adaptive Trials

Complimentary Webinar Thursday, April 7th at 11:00 AM…
Read Article

Medelis co-founder Daniel Von Hoff receives prestigious ASCO scientific honor

We are pleased to share the news that…
Read Article

Dr. Alan Sandler, Dr. James Cassidy Join Medelis’ Medical Advisory Board

We’re pleased to announce more company news today:…
Read Article

“Context of vulnerability” and its role in targeted drug development

Renowned cancer researcher Dr. Daniel Von Hoff and…
Read Article

The “Lost Opportunity” in Phase I Oncology Trials

Cancer drug developers traditionally use the phase I…
Read Article

Dr. Dan Von Hoff honored at Governor’s Celebration

Our colleague Dan Von Hoff, M.D., a founder…
Read Article

Personalized Genomics: The First Report of a Cancer Genome

As reported by the New York Times last…
Read Article

Excellent cancer discussion on the Diane Rehm show

Yesterday morning’s Diane Rehm Show on NPR featured…
Read Article